Abstract
An Israeli R&D company has developed a technology to solve the problem of deficient and over-invasive therapeutic solutions in ophthalmology. The technology is a simple, refillable, safe implantable microscopic capsule that can access previously unreachable areas of the eye and administer medicine. This cutting-edge technological advancement not only reduces dosage, but also minimizes threats of harmful side effects. The company seeks an R&D partner to further develop the technology.
Reference Nr 12 IL 80EP 3OII


